Reference
Vallejo-Yague E, et al. Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase. Drug Safety : 12 Jun 2020. Available from: URL: https://doi.org/10.1007/s40264-020-00958-9
Rights and permissions
About this article
Cite this article
Thromboembolism with baracitinib or tofacitinib. Reactions Weekly 1809, 12 (2020). https://doi.org/10.1007/s40278-020-79796-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-79796-1